Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03082638 · ClinicalTrials.gov registry record
Identification of Gulf War Illness (GWI) Biomarkers
A clinical trial of Gulf War Illness, sponsored by Roskamp Institute.
- Completed
- Registry status
- 76
- Enrollment target
- 1
- Study location
NCT03082638: Completed study of Gulf War Illness, sponsored by Roskamp Institute.
NCT03082638 is a study of Gulf War Illness that has completed, run by Roskamp Institute. The registered enrollment target is 76 participants, below the 124-participant average among 14 other Gulf War Illness trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03082638, a study of Gulf War Illness, has completed, sponsored by Roskamp Institute.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
The scientists working on this study want to use blood samples to identify components in blood, such as protein, lipids and their breakdown products to determine if they can be used for diagnosing Gulf War Illness (GWI). An additional goal is to examine the relationship of changes in these markers with the exposures and symptoms associated with GWI. The Scientists will also prepare RNA and DNA from the blood samples for genetic analyses of certain proteins known to increase the risk for GWI. This information will be one of the factors included in the analysis of results from the protein studies.
Primary Outcome
Determine if lipids specific to inflammation, mitochondria and peroxisome function can be objective biomarkers of the CNS pathology of GWI.
Conditions Studied
Study Locations (1)
Florida
- The Roskamp Institute, Inc. - Sarasota
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2017-01-18 |
| Est. Completion | 2022-12-31 |
What the finished NCT03082638 record still lists
NCT03082638 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 124-participant average among 14 other Gulf War Illness trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Gulf War Illness appearing as the primary indexed condition, and to 0 interventions.
NCT03082638 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03082638 about?
NCT03082638 is a clinical study titled "Identification of Gulf War Illness (GWI) Biomarkers". The scientists working on this study want to use blood samples to identify components in blood, such as protein, lipids and their breakdown products to determine if they can be used for diagnosing Gulf War Illness (GWI). An additional goal is to examine the relationship of changes in these markers w...
What is the current status of trial NCT03082638?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2017-01-18. Estimated completion is 2022-12-31.
What conditions does trial NCT03082638 study?
This clinical trial studies the following conditions: Gulf War Illness.
Who is sponsoring clinical trial NCT03082638?
This trial is sponsored by Roskamp Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03082638 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03082638's enrollment target sits among peer trials
76 11th of 14 higher than 4 of 14 other Gulf War Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gulf War Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Confirmation of Diet as a Treatment for Gulf War Illness
RECRUITING · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
-
Validating Gulf War Illness Blood Biomarkers
RECRUITING
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
-
Ca-Mg Butyrate in GWI
RECRUITING · Phase 2
-
Mechanisms of Gulf War Illness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI